LC
CRDF icon

Lindbrook Capital’s Cardiff Oncology CRDF Stock Holding History

Lindbrook Capital’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,700
Closed -$11K – 2090
2021
Q3 		$11K Hold
1,700
– – ﹤0.01% 950
2021
Q2 		$11K Buy
1,700
+1,000
+143% +$8.48K ﹤0.01% 1005
2021
Q1 		$6K Buy
+700
New +$8.5K ﹤0.01% 1197
2020
Q4 		– Sell
-500
Closed -$7K – 1787
2020
Q3 		$7K Buy
+500
New +$3.3K ﹤0.01% 946

Other funds holding CRDF

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lindbrook Capital's CRDF Position: Q4 2021 in Review

Lindbrook Capital sold out of Cardiff Oncology (CRDF) in Q4 2021, closing a stake of 1,700 shares — an estimated $11K sold.

Lindbrook Capital first reported a position in CRDF in Q3 2020 and held it in 4 quarters. The position peaked at $11K in Q3 2021. 87 funds tracked by Wall St. Rank hold CRDF as of Q4 2021.

  • Lindbrook Capital reported no remaining Cardiff Oncology position as of Q4 2021 after selling out during the quarter.
  • Lindbrook Capital sold 1,700 Cardiff Oncology shares in Q4 2021, an estimated $11K.
  • Lindbrook Capital first reported a position in Cardiff Oncology in Q3 2020 and held it in 4 quarters.
  • Lindbrook Capital's Cardiff Oncology position peaked at $11K in Q3 2021.
  • 87 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2021.

Based on Lindbrook Capital's 13F filing for Q4 2021, filed 18 Jan 2022.